Researchers previously only considered ALS as one illness, but new knowledge has changed that mentality and has shown experts they need to personalize treatment approaches. “It’s important to understand the disease in different groups of people.â€
More good news on treatment for hepatitis C patients.
Certain conditions are linked to multiple sclerosis disease progression.
Could insulin could be dosed off of values from a continuous glucose monitor? Anne Peters, MD, and team sought to find out.
HPV is apparently on the rise in the United States among unvaccinated adults.
Meredith McCormack, MD, MHS, talked about managing asthma and COPD in the primary care setting and when it’s time to refer a patient to a specialist at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.
Umbilical cord blood is safe for young children with autism spectrum disorder.
Breakthrough status for a new drug to treat familial hypercholesterolemia.
Why do some patient care settings have higher rates of C. difficile infection?
Farid Saad, DVM, PhD, Bayer Pharma AG learned that the men with type 1 diabetes did experience benefits of long-term testosterone therapy – they showed improvements in their underlying diseases.
Heidi Combs, MD, says that many patients present to the primary care office thinking that they have other health problems when the diagnosis is really anxiety or depression. She discussed the topic at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.
The FDA approved new drug for two forms of multiple sclerosis.
FDA gives priority review designation for exertional heat stroke drug.
Researchers compared the safety and efficacy of leading ADHD treatments.
Researchers studied the costs associated with various C. difficile treatments.
RV/TCL ratios have a stronger association with longer duration asthma.
IBS-D treatment eluxadoline is a risk for patients who do not have gallbladders.
Patients with preoperative colorectal cancer have reported high incidence rates of C. difficile.
The phase 3b MUSCA trial reported positive results for mepolizumab.
Jay Jin, MD, PhD, Mayo Clinic, shared the results from his team's case series surrounding unexpected bradycardia effect from epinephrine administration.
Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), shared with MD Magazine what the main theme would be in his keynote address at the AAAAI 2017 meeting in Atlanta, GA: emerging and reemerging infections, a perpetual challenge.
Only a small percentage of people who think they have a penicillin allergy actually do.
How safe are anti-inflammatory medications for children?
Patients’ hospital room floors are frequently contaminated with pathogens.
Katia Boven, MD, Head of Clinical Development and Global Medical Affairs, Infectious Diseases, Janssen, discussed results and impact of the SWORD clinical trial involving the investigational two-drug combination being as effective as the three or four regimens as maintenance therapy in HIV patients who have already achieved viral suppression.
